Advanced Search

 

Study ID Status Title Patient Level Data
113922 Completed Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim
113929 Completed BRF113929: An Open-Label, Two-Cohort, Multicentre Study of GSK2118436 as a Single Agent in Treatment Naïve and Previously Treated Subjects with BRAF Mutation-Positive Metastatic Melanoma to the Brain
113935 Completed Safety and immunogenicity of GSK Biologicals’ candidate tuberculosis vaccine (692342) when administered to HIV-positive adults living in a Tuberculosis endemic region
113939 Completed Relative bioavailability study between the formulations: Paroxetine 25 mg tablet with controlled release manufactured by GSK Mississauga and Paroxetine 25 mg tablets with controlled release manufactured by SmithKline Beecham (Cidra), fasted administration in healthy volunteers for both genders.
113946 Completed An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of HYCAMTIN administered in Korean patients according to the prescribing information
113948 Completed Safety and immunogenicity of new formulations of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (GSK217744) in primary infant vaccination
113949 Completed A partially blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ Staphylococcal 4-component investigational vaccine (GSK2392102A) in healthy adults
113950 Completed A Single-Centre, Randomised, Open-label Study to Evaluate the Effects of Steady-State Verapamil, a Moderate P-Glycoprotein and CYP3A4 Inhibitor, on the Pharmacokinetics of GSK573719 and GSK573719 in Combination with GW642444 Study Listed on ClinicalStudyDataRequest.com
113951 Completed Korean’s practice patterns for screening PCA(prostate cancer) according to PSA(prostate-specific antigen) level
113954 Completed Antibody persistence and immune memory against the hepatitis B antigen in 11-12 year old children, previously vaccinated with DTPa-HBV-IPV/Hib vaccine in study 217744/031 Study Listed on ClinicalStudyDataRequest.com
113960 Terminated Clinical Outcomes on ErbB2+ MBC patients treated with Lapatinib-Capecitabine after Trastuzumab Progression: Role of early versus late switch to Lapatinib-Capecitabine (TYCO1) - Brazil
113962 Completed Risk of hemorrhage in patients prescribed Arixtra compared to LMWH
113970 Completed An open-label, non-randomized pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with severe renal impairment. Study Listed on ClinicalStudyDataRequest.com
113971 Completed An Open-Label Study to Evaluate the Effects of Ketoconazole and the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Repeat Doses of Pazopanib in Subjects with Solid Tumor Malignancies
113973 Completed A retrospective cohort study to evaluate the rate of good responses to lamivudine (LAM) treatment in naïve Chronic Hepatitis B (CHB) patients with certain pre-treatment characteristics
113977 Completed Persistence of antibodies after vaccination with a dose of GSK Biologicals’ meningococcal vaccine GSK134612 in healthy children and safety and immunogenicity of a booster dose at 68 months post-primary vaccination
113978 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine administered as a booster dose in 12-18 months old healthy children Study Listed on ClinicalStudyDataRequest.com
113979 Completed Economic Analyses Alongside the REDUCE Clinical Trial
113984 Completed Dutasteride in Enlarged Prostate economic assessment: A retrospective database pooled analysis of early 5-alpha reductase inhibitor use
113985 Completed AVANDIA® (rosiglitazone maleate) 2009 Update to Integrated Cardiovascular (CV) Endpoint data from the Final Analyses for Studies BRL-049653/048 (ADOPT), AVD107642 (DREAM), and BRL-049653/231 (RECORD).
113989 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and FF Inhalation Powder in Japanese Subjects with asthma Study Listed on ClinicalStudyDataRequest.com
113994 Completed Safety, reactogenicity & immunogenicity of GSK Biologicals’ pneumococcal vaccine 2189242A when co-administered with DTPa-HBV-IPV/Hib vaccine in healthy infants
114000 Completed A study to evaluate the safety and efficacy of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in children aged 6 months to less than 10 years of age Study Listed on ClinicalStudyDataRequest.com
114001 Completed Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
114002 Completed proportion of ocular symptoms in patients with allergic rhinitis in Korea

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.